ClinicalTrials.Veeva

Menu

Comparison of Three Methods of Hemoglobin Monitoring

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Completed

Conditions

Digital Block

Treatments

Device: Masimo SpHb continuous hemoglobin monitor
Drug: Lidocaine digital block

Study type

Interventional

Funder types

Other

Identifiers

NCT01284296
10-00524B

Details and patient eligibility

About

This study will further investigate the Masimo SpHb [FDA Approved] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).

Full description

We have completed a study with 20 patients using the latest version of the SpHb monitor software and finger sensor.

The purpose of this study is to assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb) following the digital block.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or non-pregnant female 18 y/o or older
  • ASA Classification 1, 2 or 3
  • Scheduled to undergo spine or hip revision surgery

Exclusion criteria

  • Pregnant or nursing
  • Patients who in the study investigators clinical judgement would not be suitable for research.

Trial design

20 participants in 1 patient group

Digital block
Experimental group
Treatment:
Device: Masimo SpHb continuous hemoglobin monitor
Drug: Lidocaine digital block

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems